Alerts will be sent to your verified email
Verify Email
WELCURE
|
Welcure Drugs&Pharma
|
Binny Mills
|
Integ.Pro
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
43.2 % | 2.38 % | 1.64 % |
|
5yr average Equity Multiplier
|
-0.38 | -1.02 | 1.18 |
|
5yr Average Asset Turnover Ratio
|
0.25 | 0.04 | 0.16 |
|
5yr Avg Net Profit Margin
|
-80.17 % | -67.35 % | 11.46 % |
|
Price to Book
|
0.46 | 0.0 | 3.14 |
|
P/E
|
1.78 | 0.0 | 192.18 |
|
5yr Avg Cash Conversion Cycle
|
2364.01 Days | 15.76 Days | -69.58 Days |
|
Inventory Days
|
20.66 Days | 84.09 Days | 0.0 |
|
Days Receivable
|
1232.42 Days | 20.05 Days | 0.0 |
|
Days Payable
|
0.0 | 129.33 Days | 52.34 Days |
|
5yr Average Interest Coverage Ratio
|
-2.67 | 0.6 | 1275.33 |
|
5yr Avg ROCE
|
-7.19 % | -152.87 % | 2.02 % |
|
5yr Avg Operating Profit Margin
|
-81.01 % | 5.31 % | -20.12 % |
|
5 yr average Debt to Equity
|
-0.35 | -0.82 | 0.06 |
|
5yr CAGR Net Profit
|
-2.01 % | n/a | 65.72 % |
|
5yr Average Return on Assets
|
-1.33 % | -3.02 % | 1.46 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
0.0 | 68.97 % | 13.04 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -5.89 % | -33.19 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Welcure Drugs&Pharma
|
Binny Mills
|
Integ.Pro
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|